The Daily SignalOctober 7, 2026

FDA Clears First Digital Therapeutic for Negative Schizophrenia Symptoms.

PLUS: How Genmab and AbbVie's bispecific cut lymphoma progression by 51%.

By Dr. Dereck Mush

MD, MBA

Published October 7, 2026

Archive
ShareLink copied
FDA Clears First Digital Therapeutic for Negative Schizophrenia Symptoms.
ShareLink copied

Related reading

Your daily HealthTech Signal

No hype. Just signal.

Get the latest HealthTech news, understand why it matters, and see where the industry is headed.

5-minute read Delivered daily Unsubscribe anytime

Read by teams at companies like:

Mayo Clinic logoMayo ClinicCleveland Clinic logoCleveland ClinicJohns Hopkins logoJohns HopkinsKaiser Permanente logoKaiser PermanenteEpic logoEpicPhilips logoPhilipsMedtronic logoMedtronicGE HealthCare logoGE HealthCare